Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Revenue:
Total revenue	$ 315,902	$ 146,135	$ 663,927	$ 308,733
Operating expenses
Cost of revenue	235,714	170,526	466,719	367,207
Selling, general and administrative expenses	2,042,609	2,444,586	4,373,443	4,991,714
Research and development expenses	83,850	190,761	157,370	294,941
Depreciation and amortization	19,705	22,083	38,792	37,630
Total operating expenses	2,381,879	2,827,956	5,036,324	5,691,492
Loss from operations	(2,065,977)	(2,681,821)	(4,372,397)	(5,382,759)
Other income (expense):
Income (loss) from equity method joint ventures	3,788	(117,978)	(23,947)	(189,095)
Interest income		48		273
Interest expense	(175,192)	(102)	(391,781)	(1,558)
Foreign currency exchange loss	(265)	(888)	(400)	(1,914)
Total other income (expense)	(171,669)	(118,920)	(416,128)	(192,294)
Net loss before income taxes	(2,237,646)	(2,800,741)	(4,788,525)	(5,575,053)
Income taxes	2,865	800	2,865	800
Net loss	$ (2,240,511)	$ (2,801,541)	$ (4,791,390)	$ (5,575,853)
Net loss per common share:
Basic	$ (3.06)	$ (4.62)	$ (7.07)	$ (9.23)
Diluted	$ (3.06)	$ (4.62)	$ (7.07)	$ (9.23)
Weighted average number of common shares outstanding:
Basic	732,255	605,760	677,684	604,123
Diluted	732,255	605,760	677,684	604,123
Clinic Revenue [Member]
Revenue:
Total revenue	$ 254,364	$ 112,358	$ 551,745	$ 218,206
Product [Member]
Revenue:
Total revenue	$ 61,538	$ 33,777	$ 112,182	$ 90,527